CALL FOR PROPOSALS: Regional Prospective Observational Research in Tuberculosis (RePORT) Philippines Phase II: U.S. NIH – PCHRD Collaborative Research Call for Tuberculosis (CoRe TB)

The U.S. National Institutes of Health and the Department of Science and Technology (DOST), through the National Institute of Allergy and Infectious Diseases (NIAID) and Philippine Council for Health and Research Development (PCHRD), invite researchers to submit concept proposals for the “Regional Prospective Observational Research in Tuberculosis (RePORT) Philippines Phase II: U.S. NIH – PCHRD Collaborative Research Call for Tuberculosis (CoRe TB).”

This initiative will provide a maximum of three (3) years of funding to support six (6) high-quality collaborative research projects focused on research in tuberculosis (TB) and related coinfections and comorbidities, such as HIV infection, Diabetes, and COVID-19, to address TB research needs.

This research call is a two-stage process wherein applicants are expected to submit an initial concept proposal. Ten (10) concept proposals will be selected and invited to submit a full proposal. Travel awards will be provided to each project team who wishes to travel and develop their full proposal with their collaborators. Six (6) high-quality full proposals will be approved for funding.



  •  Concept Proposal Submission Deadline:

Wednesday, December 7, 2022 (11:59 AM) U.S. Eastern Standard Time (EST)

Wednesday, December 7, 2022 (11:59 PM) Philippine Standard Time (PST)

  • Full Proposal Submission Deadline:

Friday, April 7, 2023 (11:59 AM) U.S. Eastern Time (ET)

Friday, April 7, 2023 (11:59 PM) Philippine Standard Time (PST)



The focus of the call is to support research in tuberculosis (TB), including drug-resistant TB and related coinfections (e.g., COVID-19 and HIV). Areas of research interest include the following: 

  • Genomic and Molecular Technologies: Novel biomarker identification, with focus on pathogenomics and host-pathogen interactions. 
  • Diagnostics: Development of cost-effective diagnostic tools (e.g., point of care, differential/ discriminatory, confirmatory, and early detection) for TB, and utilizing or repurposing off-patent or lapsed and/ or novel technologies. 
  • Vaccines and Therapeutics: Exploratory/ applied research which might lead to the development of new and more effective prevention or therapeutic strategies. 
  • Information and Communication Technology (ICT)/ e-health: Development of user-friendly ICT solutions to accelerate the gathering and processing of health and related information for policy making, and delivery of quality healthcare services. 


PROJECT DURATION: Minimum of two (2) years, maximum of three (3) years 

AWARD AMOUNT: Six (6) full proposals will be awarded up to $500,000 USD each


  • U.S.: National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) 
  • Philippines: Department of Science and Technology (DOST), Philippine Council for Health Research and Development (PCHRD) 



  • Technical/ Scientific Inquiries:

Dr. Albert Remus Rosana (

  • Administrative Inquiries:

Ms. Louise Sky Olaguer (

Follow Us
Contact Us
Saliksik Building, DOST Compound, Gen. Santos Ave., Bicutan Taguig City 1631 Philippines,
Trunk Lines: 8837-2931; 8837-0087; 8837-2924
Direct Lines: 8837-2942; 8837-7536; 8837-0031; 8837-7535; 8837-7534; 8837-7537
Map and Location
Skip to content